GSK to shut vaccine factory in Germany |
| GlaxoSmithKline is to close a vaccine plant in Dresden, Germany, next year. German trade union Industriegewerkschaft Bergbau, Chemie, Energie (IGBCE) said the closure would put 641 jobs at risk. "With decreasing demand for traditional egg-based flu vaccines, meaning we have more capacity than we need, we've conducted a review of the viability of our two flu vaccines manufacturing sites in Dresden, Germany, and Ste-Foy, Canada," GSK said. "Following this, we have taken a difficult decision to consolidate operations at one site. We have selected the site in Canada, which can fully match anticipated future demand in a sustainable and competitive way." |
|